US 8183212
Compound having GPR54 agonistic activity
granted A61KA61K38/00A61P
Quick answer
US patent 8183212 (Compound having GPR54 agonistic activity) held by Takeda Pharmaceutical Company Limited expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/00, A61P, A61P15/00, A61P15/08